A real signal in the trials and a real problem in the absorption. Both halves belong on the label.
Curcumin is the yellow pigment of turmeric and the most studied anti-inflammatory phytochemical. The osteoarthritis trials are the strongest part of its literature, and pooled analyses generally favour curcumin over placebo for pain and function in knee osteoarthritis, with effect sizes comparable to some NSAIDs in the better trials and very small trials dominating. The certainty is limited and the heterogeneity is real; the direction is consistent.
The absorption problem is the central fact about curcumin. On its own it is poorly absorbed: it is rapidly glucuronidated and sulfated in the gut wall and liver, and the fraction reaching plasma is a small percentage. This is why a curry and a clinical trial are not the same thing. Trials use formulations built to overcome it — phospholipid complexes, micellar or nanoparticle preparations, or the addition of piperine from black pepper, which inhibits the glucuronidation and raises plasma levels substantially.
Piperine cuts both ways. It raises curcumin levels by inhibiting CYP3A4 and P-glycoprotein. The same enzymes clear other drugs. A person taking curcumin with piperine is also raising the level of anything else they take that goes through that route, and that is not a theoretical concern with a narrow-index drug.
What a household can reasonably do. Cook with turmeric as food — it is safe, it is a good idea for other reasons, and it is not a therapeutic dose. Take a standardised extract with a documented absorption strategy if using it for a joint, and check every medicine first. Topical NSAIDs and exercise have better evidence than curcumin does for knee osteoarthritis, and both are cheaper.
Safety. Curcumin is generally well tolerated; it can cause GI upset, it can increase bleeding risk with anticoagulants, and there are rare reports of liver injury with high-dose supplements.
Meta-Analysis2025Nutrients
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
Background: Knee osteoarthritis (KOA) is a prevalent degenerative joint disease that can greatly affect quality of life in middle-aged and elderly individuals.
PubMed 40806131 ↗
Meta-Analysis2025BMC complementary medicine and therapies
Effects of curcumin on serum inflammatory biomarkers in patients with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
Curcumin led to a decrease in the serum CRP and TNF-alpha levels in patients with knee OA.
PubMed 40615851 ↗
Meta-Analysis2025BMC complementary medicine and therapies
Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis.
All turmeric preparations appear to be effective in reducing knee OA pain when used as monotherapy compared to placebo.
PubMed 40731001 ↗
Meta-Analysis2024Phytotherapy research : PTR
The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
The results strongly support curcuminoid supplementation in relieving pain, improving joint mobility and stiffness, and shortening medication usage of OA patients.
PubMed 38576215 ↗
Meta-Analysis2024Journal of ethnopharmacology
Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
Curcumin, either alone or in combination with other treatments, is considered to have good clinical efficacy and safety in KOA treatment.
PubMed 38036015 ↗
Meta-Analysis2022Nutrients
A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.
Other studies are needed to better assess the effects of omega-3 and vitamin D.
PubMed 35458170 ↗